Form EFFECT Outlook Therapeutics,
Tweet
Share
E-mail| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | July 21, 2026 4:30 P.M. |
| Form: | S-3 | ||||||
| |||||||
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Korea Zinc Urges Shareholders to Vote for Long-Term Corporate Value as Leading Proxy Advisors, Including ISS and Glass Lewis, Recommend Support for Board Nominee
- Form 8.5 (EPT/RI) - Kore Potash Plc
- Danske Bank share buy-back programme: transactions in week 36
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
